Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001403752-22-000013
Filing Date
2022-05-04
Accepted
2022-05-04 16:13:45
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyme-20220331.htm   iXBRL 10-Q 1444307
2 EX-31.1 zyme-20220331xex311.htm EX-31.1 8781
3 EX-31.2 zyme-20220331xex312.htm EX-31.2 8674
4 EX-32.1 zyme-20220331xex321.htm EX-32.1 5599
5 EX-32.2 zyme-20220331xex322.htm EX-32.2 5665
  Complete submission text file 0001403752-22-000013.txt   5705365

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zyme-20220331.xsd EX-101.SCH 38833
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zyme-20220331_cal.xml EX-101.CAL 67936
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zyme-20220331_def.xml EX-101.DEF 149419
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zyme-20220331_lab.xml EX-101.LAB 486326
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zyme-20220331_pre.xml EX-101.PRE 304410
60 EXTRACTED XBRL INSTANCE DOCUMENT zyme-20220331_htm.xml XML 807210
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38068 | Film No.: 22891660
SIC: 2834 Pharmaceutical Preparations